Dr. Ravi V. Nerella, MD

Dr. Nerella practices at Mercy Hospital Springfield & Children's Mercy in Springfield, Missouri.

Dr. Nerella's NPI, 1114082567, was assigned on December 26, 2006. Dr. Nerella holds Missouri license 2005000623.

Dr. Nerella's primary practice is Mercy Hospital Springfield & Children's Mercy, at 1235 E Cherokee St, Springfield, MO 65804 in Greene County. The practice phone is (417) 820-2000.

Dr. Nerella's primary practice is Mercy Hospital Springfield & Children's Mercy in Springfield, Missouri. Dr. Nerella is also affiliated with Mercy Hospital Springfield. The medical group on file is Mercy Clinic Family Medicine - Hollister.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nerella practices. Vendor and product names are available with a free account.

Hospitalist is Dr. Nerella's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Nerella is licensed in Missouri.

CMS data shows 630 Medicare services from Dr. Nerella across 5 procedure codes in 2024, for 228 Medicare patients. Medicare paid $46,593 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 228 Medicare patients who saw Dr. Nerella in 2024. The largest group is 75 to 84, with 85 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nerella's median patient age at 74, with 51% women.

In 2024, Dr. Nerella wrote 623 Medicare Part D claims for 193 patients. 83% of them were for generic drugs. CMS names the drug for 385 of them, across 16 drugs with 11 or more claims each, at $45,155 in total drug cost. In 2023, CMS named 572 claims across 22 drugs.

Dr. Nerella accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Dr. Nerella from 4 drug and device companies from 2017 to 2022. Speaker and faculty fees make up the largest share, 67% of the total. Eko Devices, Inc. paid the most, $225.